Cite
HARVARD Citation
Routh, E. et al. (2023). Evaluation of tumor antigen-specific antibody responses in patients with metastatic triple negative breast cancer treated with cyclophosphamide and pembrolizumab. Journal for immunotherapy of cancer. 11 (3), p. . [Online].